This study is a randomized, observer-blinded, placebo-controlled study to evaluate safety, tolerability, immunogenicity, and pharmacokinetics of repeat dosing of intravenous (IV) UTTR1147A. The study will consist of a repeat dose escalation in healthy volunteers (HV) and a repeat dose escalation in Ulcerative Colitis (UC) patients across multiple sites.